Abstract:OBJECTIVE:To investigate the efficacy of inducing apoptosis in human bladder cancer cells by adriamycin and mitomycin and relevant mechanism.METHODS:Human bladder cancer cells of the lines RT4, MGH-U1, FJ, and T24 were cultured. Adriamycin of the concentrations of 0.1, 1, and 10 microg/ml, and mitomycin of the concentrations of 0.01, 0.1, and 1 microg/ml were added into the culture fluid respectively. CCK-8 colorimetric assay was used to detect the survival rates of the cells so as to select the cell line sensitive and tolerable to the drugs. Flow cytometry was used to detect the cell apoptosis. Western blotting was used to detect the levels of X-kinked inhibitor of apoptosis protein (XIAP) and the cleavage of caspase-3 precursor.RESULTS:It was found that RT4 cells were the most sensitive and the T24 cells were the most tolerable to adriamycin and mitomycin. Treated with adriamycin of the concentrations of 0.1, 1, and 10 microg/ml for 24 hours, the apoptotic rates of the RT4 cells were 15.3% +/- 4.3%, 29.3% +/- 6.4%, and 45.0% +/- 5.5% respectively; and the apoptotic rates of the T24 cells were 7.3% +/- 3.1%, 12.5% +/- 4.3%, and 18.2% +/- 6.3% respectively, all significantly lower than those of the RT4 cells (P < 0.05 or P < 0.01). Treated with mitomycin of the concentrations of 0.01, 0.1, and 1 microg/ml for 24 hours, the apoptotic rates of the RT4 cells were 12.7% +/- 2.9%, 31.3% +/- 4.4%, and 48.9% +/- 5.8% respectively, and the apoptotic rates of the RT4 cells were 7.2% +/- 3.3%, 15.5% +/- 5.2%, and 21.2% +/- 4.4% respectively, all significantly lower than those of the RT4 cells (all P < 0.05). The XIAP expression was not significantly different in these 4 cell lines before the adriamycin and mitomycin treatment. After the treatment of adriamycin and mitomycin, the expression of XIAP was down-regulated dose-dependently, however, being weaker in the T24 cells than in the RT4 cells; and caspase-3 precursor cleavage was enhanced, however, being weaker in the T24 cells too.CONCLUSION:Adriamycin and mitomycin dose-dependently kill the human bladder cancer cells. Such cytotoxic effect may be realized through inducing the cell apoptosis which is associated with the down-regulation of XIAP and cleavage of caspase-3 precursor.

Preparation of adriamycin-liposome and its cytotoxicity on human ovarian carcinoma SKOV3 cells in vitro

Knockdown of STAT3 Expression in SKOV3 Cells by Biodegradable Sirna–plga/cso Conjugate Micelles

Establishment of a new paclitaxel resistant cell line of human ovarian carcinoma and preliminary observation of its biology.

Antitumor efficacy of adriamycin encapsulated in liposomes in mice

[Inhibitory and Apoptosis Regulating Effects of Adriamycin on Different Human Breast Cancer Cell Lines].

Anti-tumor Effect and Its Antigenic Specificity of Cytotoxicity T Lymphocytes Induced by SKOV3 Ovarian Carcinoma Cell Line Freeze-thaw Antigen

The Effect of Triptolide-Loaded Exosomes on the Proliferation and Apoptosis of Human Ovarian Cancer SKOV3 Cells

Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies

LFG-500, a newly synthesized flavonoid, induces apoptosis in human ovarian carcinoma SKOV3 cells with involvement of the reactive oxygen species-mitochondria pathway

Effect of Tamoxifen, Methoxyprogesterone Acetate and Combined Treatment on Cellular Proliferation and Apoptosis in SKOV3/DDP Cells Via the Regulation of Vascular Endothelial Growth Factor

The anti-ovarian cancer effect of RPV modified paclitaxel plus schisandra B liposomes in SK-OV-3 cells and tumor-bearing mice

Adriamycin-loaded Gelatin Microspheres in the Treatment of Bone Tumors

Preparation and Preliminary Safety Evaluation of Carboplatin Proliposomes

In Vitro Investigation of RGD-modified Stabilized Cationic Liposomes As Non-Viral Vehicle for Sirna Delivery

[Experimental Study on Resistance to Cisplatin and Taxol in Human Ovarian Cancer SKOV3ip1 Multicellular Aggregates].

Lipoperoxide Nanoemulsion as Adjuvant in Cisplatin Cancer Therapy: In Vitro Study on Human Colon Adenocarcinoma DLD-1 Cells

Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)- b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer

Preparation and properties of tumor-targeting lentinan-oleic acid polymer micelles based on folic acid for adriamycin delivery

Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin

Adriamycin and Mitomycin Dose-Dependently Downregulate X-kinked Inhibitor of Apoptosis Protein in Human Bladder Cancer Cells

In vitro and in vivo evaluation of cationic liposomes containing zoledronic acid as anticancer agent